Register

Today

For Valuable Updates and Resources

Skeletal

Clinical snapshot

Over time, systemic consequences can impact quality of life.1

86% (n=44) of pediatric patients reported pain.2,a
Pain impairs mobility, function, and activities of daily living.1-3
aThe HPP Impact Patient Survey (HIPS) was an Internet questionnaire that queried demographics, hypophosphatasia-related illness history, disease progression, and health-related quality of life. One hundred thirty-three patients participated.2

Skeletal manifestations can have devastating lifelong impacts for patients with hypophosphatasia (HPP).1,4-14

Patients with hypophosphatasia may experience4,6-15:

Severe hypomineralization
Progressive skeletal demineralization
Hypophosphatasia-induced rickets
Bowing
Skeletal deformities
Bone pain
Osteomalacia
Frequent, nonhealing, nontraumatic, or recurrent fractures
Short stature
Multiple surgical interventions

Hypophosphatasia-induced rickets can have a lasting impact on mobility.4,7

Hypophosphatasia-induced rickets can lead to short stature, delayed walking, and waddling gait7,16,17
83% (5/6) of pediatric patients (5 to 15 years of age) had bowing of the long bones due to hypophosphatasia-induced rickets3,b

In patients with hypophosphatasia, the increasing number of recorded fractures suggests progressive morbidity as patients age.1,15,19

23% (7/30) of infants and young children experience fractures20,c
34% (11/32) of pediatric patients (5 to 15 years of age) experience fractures21,d
86% (108/125) of adult patients report fractures1,e
Adults with hypophosphatasia suffer from a large number of fractures (12.9 [mean] fractures [SD±19.0, range: 1-100])1,2,e

Devastating skeletal manifestations can progressively worsen across a lifetime in patients with hypophosphatasia.1,4,15,18

bData from a retrospective, noninterventional substudy of children (n=6) enrolled in a larger retrospective, multinational, noninterventional natural history study of childhood hypophosphatasia (N=32).3

cData from a noninterventional, retrospective chart review study designed to understand the natural history of 48 patients with severe perinatal and infantile-onset hypophosphatasia ≤5 years of age.20

dData from a retrospective, multinational, noninterventional natural history study of childhood hypophosphatasia (N=32).21

eHIPS/HPP Outcomes Survey Telephone (HIPS/HOST) combined data from an Internet questionnaire and telephone survey that queried demographics, hypophosphatasia-related illness history, disease progression, and health-related quality of life. One hundred eighty-four patients participated (59 children, 125 adults).1,2

I would like to be contacted by Alexion Pharmaceuticals, Inc. to learn more about hypophosphatasia.

By clicking "SUBMIT" I agree to the Terms of Use.

References: 1. Weber TJ, Sawyer EK, Moseley S, Odrljin T, Kishnani PS. Burden of disease in adult patients with hypophosphatasia: results from patient-reported outcome surveys [abstract FRI-240]. Endocrine Society’s 97th Annual Meeting and Expo website. https://endo.confex.com/endo/2015endo/webprogram/Paper20871.html. Accessed July 13, 2015. 2. Data on file, Alexion Pharmaceuticals. 3. Phillips D, Griffin D, Przybylski T, et al. Gait assessment in children with childhood hypophosphatasia: impairments in muscle strength and physical function. Poster presented at: Endocrine Society Annual Meeting; March 5-8, 2015; San Diego, CA. 4. Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013;10(suppl 2):380-388. 5. Fraser D. Hypophosphatasia. Am J Med. 1957;22(5):730-746. 6. Whyte MP, Greenberg CR, Salman N, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012;366(10):904-913. 7. Whyte MP. Hypophosphatasia. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T, eds. Genetics of Bone Biology and Skeletal Disease. London, UK: Academic Press; 2013:337-360. 8. Beck C, Morbach H, Wirth C, Beer M, Girschick HJ. Whole-body MRI in the childhood form of hypophosphatasia. Rheumatol Int. 2011;31(10):1315-1320. 9. Kozlowski K, Sutcliffe J, Barylak A, et al. Hypophosphatasia: review of 24 cases. Pediatr Radiol. 1976;5(2):103-117. 10. Moulin P, Vaysse F, Bieth E, et al. Hypophosphatasia may lead to bone fragility: don’t miss it. Eur J Pediatr. 2009;168(7):783-788. 11. Coe JD, Murphy WA, Whyte MP. Management of femoral fractures and pseudofractures in adult hypophosphatasia. J Bone Joint Surg Am. 1986;68(7):981-990. 12. Gagnon C, Sims NA, Mumm S, et al. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. J Clin Endocrinol Metab. 2010;95(3):1007-1012. 13. Schalin-Jäntti C, Mornet E, Lamminen A, Välimäki MJ. Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J Clin Endocrinol Metab. 2010;95(12):5174-5179. 14. Taketani T, Onigata K, Kobayashi H, Mushimoto Y, Fukuda S, Yamaguchi S. Clinical and genetic aspects of hypophosphatasia in Japanese patients. Arch Dis Child. 2014;99(3):211-215. 15. Whyte MP. Hypophosphatasia: nature’s window on alkaline phosphatase function in humans. In: Bilezikian JP, Raisz LG, Martin TJ, eds. Principles of Bone Biology. Vol 2. 3rd ed. San Diego, CA: Academic Press; 2008:1573-1598. 16. Whyte MP. Hypophosphatasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. Vol 4. 8th ed. New York, NY: McGraw-Hill; 2001. 17. Mornet E, Nunes ME. Hypophosphatasia. In: Pagon RA, Bird TD, Dolan CR, Stephen K, eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 1993. http://www.ncbi.nlm.nih.gov/books/NBK1150/. Published November 20, 2007. Updated August 5, 2010. Accessed March 27, 2015. 18. Sutton RA, Mumm S, Coburn SP, Ericson KL, Whyte MP. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res. 2012 May;27(5):987-94. 19. Simmons JH. Best practices in: recognizing and diagnosing hypophosphatasia. Clinical Endocrinology News 2013 [cited 2015 May 12, 2015]; Available from: http://www.clinicalendocrinologynews.com
/fileadmin/content_pdf/cen/Alexion_10_11_Final_Web.pdf. 20. Whyte MP, Leung E, Wilcox W, et al. for Study 011-10 Investigators. Hypophosphatasia: a retrospective natural history study of the severe perinatal and infantile forms. Poster presented at: 2014 Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; May 3-6, 2014; Vancouver, BC. 2014. 21. Whyte MP, Zhang F, Wenkert D, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. 2015 Jun;75:229-39.